Immune responsiveness during disease progression from acute rheumatic fever to chronic rheumatic heart disease

Devinder Toor1, Harpreet Vohra

  • 1Department of Experimental Medicine and Biotechnology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Insights

Streptococcus pyogenes infection can lead to acute rheumatic fever (ARF) and rheumatic heart disease (RHD). This study reveals altered T-cell proportions and a shift in cytokine profiles (Th1 to Th2) as ARF progresses to RHD, indicating key roles for IL-6 and TNF-α.

Area of Science:

  • Immunology
  • Cardiovascular Disease
  • Microbial Pathogenesis

Background:

  • Streptococcus pyogenes infection in children can lead to acute rheumatic fever (ARF).
  • Untreated ARF may progress to rheumatic heart disease (RHD), a significant cause of acquired heart valve damage.
  • The precise immunological mechanisms driving ARF and RHD pathogenesis remain incompletely understood.

Purpose of the Study:

  • To investigate the changes in T-cell populations (CD4+ and CD8+) in patients with ARF, RHD, and chronic RHD.
  • To analyze the production of Th1/Th2 cytokines in the serum and heart valve endothelial cells of patients across different disease stages.
  • To elucidate the immunological pathways involved in the progression from ARF to RHD.

Main Methods:

  • Flow cytometry was employed to quantify CD4+ and CD8+ T-cell percentages in patient cohorts.
  • Serum and endothelial cell samples were analyzed for Th1/Th2 cytokine production using flow cytometry.
  • Comparative analysis was performed between patients with ARF, RHD, and chronic RHD, as well as with healthy controls.

Main Results:

  • An inverse relationship was observed between CD4+ and CD8+ T-cell counts in patients with ARF and RHD.
  • Cytokine assays indicated a shift from Th1 to Th2 immune responses as the disease advanced.
  • Elevated levels of IL-6 were found in ARF patients, while TNF-α was significantly high in early RHD patients.

Conclusions:

  • The findings suggest a dynamic alteration in T-cell subsets and cytokine profiles during the progression of rheumatic fever to rheumatic heart disease.
  • High IL-6 in ARF may be linked to antibody production, while TNF-α appears to play a role in RHD progression and tissue damage.
  • These immunological insights provide a basis for understanding the post-infectious sequelae of Streptococcus pyogenes and may inform future therapeutic strategies.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
590
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
281
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
295
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
508
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
454
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K